Healthcare -
Biotechnology - NASDAQ - US
$ 59.76
1.03 %
$ 7.36 B
Market Cap
17.42
P/E
HALO - OPERATING INCOME
Operating Income HALO - Halozyme Therapeutics, Inc.
551 M
LAST VALUE
43.57%
2 YEAR CAGR
58.98%
5 YEAR CAGR
26.80%
10 YEAR CAGR